3,5-bis(trifluoromethyl)benzyl n-acetyltryptophan has been researched along with enkephalin, leucine-2-alanine in 1 studies
Studies (3,5-bis(trifluoromethyl)benzyl n-acetyltryptophan) | Trials (3,5-bis(trifluoromethyl)benzyl n-acetyltryptophan) | Recent Studies (post-2010) (3,5-bis(trifluoromethyl)benzyl n-acetyltryptophan) | Studies (enkephalin, leucine-2-alanine) | Trials (enkephalin, leucine-2-alanine) | Recent Studies (post-2010) (enkephalin, leucine-2-alanine) |
---|---|---|---|---|---|
75 | 0 | 24 | 1,581 | 23 | 74 |
Protein | Taxonomy | 3,5-bis(trifluoromethyl)benzyl n-acetyltryptophan (IC50) | enkephalin, leucine-2-alanine (IC50) |
---|---|---|---|
Delta-type opioid receptor | Mus musculus (house mouse) | 0.0915 | |
Delta-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0017 | |
Kappa-type opioid receptor | Mus musculus (house mouse) | 0.009 | |
Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0419 | |
Kappa-type opioid receptor | Cavia porcellus (domestic guinea pig) | 1.4691 | |
Mu-type opioid receptor | Mus musculus (house mouse) | 0.009 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Davis, P; Hruby, VJ; Lai, J; Ma, SW; Moye, S; Nair, P; Navratilova, E; Porreca, F; Tumati, S; Vanderah, TW; Yamamoto, T; Yamamura, HI | 1 |
1 other study(ies) available for 3,5-bis(trifluoromethyl)benzyl n-acetyltryptophan and enkephalin, leucine-2-alanine
Article | Year |
---|---|
Design, synthesis, and biological evaluation of novel bifunctional C-terminal-modified peptides for delta/mu opioid receptor agonists and neurokinin-1 receptor antagonists.
Topics: Analgesics; Animals; Cell Line; Drug Design; Guinea Pigs; Humans; Ileum; In Vitro Techniques; Ligands; Male; Mice; Mice, Inbred ICR; Muscle Contraction; Muscle, Smooth; Neurokinin-1 Receptor Antagonists; Oligopeptides; Radioligand Assay; Rats; Receptors, Opioid, delta; Receptors, Opioid, mu; Structure-Activity Relationship; Vas Deferens | 2007 |